106 related articles for article (PubMed ID: 20727673)
41. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
[TBL] [Abstract][Full Text] [Related]
43. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
[TBL] [Abstract][Full Text] [Related]
44. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
[TBL] [Abstract][Full Text] [Related]
45. Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU.
Kim NH; Kim SN; Oh JS; Lee S; Kim YK
Biochem Biophys Res Commun; 2012 Feb; 418(4):616-21. PubMed ID: 22301191
[TBL] [Abstract][Full Text] [Related]
46. Associations between gene polymorphisms of thymidylate synthase with its protein expression and chemosensitivity to 5-fluorouracil in pancreatic carcinoma cells.
Zhang Q; Zhao YP; Liao Q; Hu Y; Xu Q; Zhou L; Shu H
Chin Med J (Engl); 2011 Jan; 124(2):262-7. PubMed ID: 21362378
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest.
Yoshiba S; Ito D; Nagumo T; Shirota T; Hatori M; Shintani S
Oral Oncol; 2009 Feb; 45(2):109-15. PubMed ID: 18710819
[TBL] [Abstract][Full Text] [Related]
48. Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.
Matsuzaki T; Yashiro M; Kaizaki R; Yasuda K; Doi Y; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2009 Dec; 100(12):2402-10. PubMed ID: 19764996
[TBL] [Abstract][Full Text] [Related]
49. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
50. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells.
Shigematsu H; Yoshida K; Sanada Y; Osada S; Takahashi T; Wada Y; Konishi K; Okada M; Fukushima M
Int J Cancer; 2010 Jun; 126(11):2716-25. PubMed ID: 19856312
[TBL] [Abstract][Full Text] [Related]
51. [Isolation of gastric cancer stem cells based on colony morphology and detection of their sensitivity to 5-fluorouracil].
Zhou ZH; Zhang JD; Xu GF; Zhao HB
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr; 16(4):376-80. PubMed ID: 23608803
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer.
Mansure JJ; Nassim R; Chevalier S; Rocha J; Scarlata E; Kassouf W
Cancer Biol Ther; 2009 Dec; 8(24):2339-47. PubMed ID: 20061787
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K
Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117
[TBL] [Abstract][Full Text] [Related]
54. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.
Taguchi F; Kodera Y; Katanasaka Y; Yanagihara K; Tamura T; Koizumi F
Invest New Drugs; 2011 Dec; 29(6):1198-205. PubMed ID: 20532589
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of mTOR suppresses human gallbladder carcinoma cell proliferation and enhances the cytotoxicity of 5-fluorouracil by downregulating MDR1 expression.
Li Q; Mou LJ; Tao L; Chen W; Sun XT; Xia XF; Wu XY; Shi XL
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1699-706. PubMed ID: 27212159
[TBL] [Abstract][Full Text] [Related]
57. Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer.
Tsujinaka T; Kido Y; Shiozaki H; Iijima S; Homma T; Sakaue M; Mori T
Cancer; 1992 Dec; 70(12):2761-5. PubMed ID: 1451052
[TBL] [Abstract][Full Text] [Related]
58. Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth.
Pelà M; Saxena P; Luciani R; Santucci M; Ferrari S; Marverti G; Marraccini C; Martello A; Pirondi S; Genovese F; Salvadori S; D'Arca D; Ponterini G; Costi MP; Guerrini R
J Med Chem; 2014 Feb; 57(4):1355-67. PubMed ID: 24450514
[TBL] [Abstract][Full Text] [Related]
59. mTOR inhibitors in polycystic kidney disease.
Watnick T; Germino GG
N Engl J Med; 2010 Aug; 363(9):879-81. PubMed ID: 20581393
[No Abstract] [Full Text] [Related]
60. [RAD001 reverses radio-resistance and exerts synergistic tumor inhibition with 5-fluorouracil].
Xin Y; Cong W; Zhou N; Hong DF; Cai XJ
Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(36):2564-7. PubMed ID: 22321888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
